NEW YORK (Reuters) - Valeant Pharmaceuticals International Inc was sued on Monday by buyers of its drugs, who claimed they were forced to pay exorbitant prices stemming from the Canadian company's ties to a specialty pharmacy that helped boost sales.
Read more
No comments:
Post a Comment